WuXi Oncology Receives Award for “Most Valuable Team Player ” from Genentech

We are honored to receive the Award for "Most Valuable Team Player" from Genentech in October 2013, in recognition of the contribution of the Oncology team in accelerating key deliveries with...

WuXi Successfully Completes Its First 2000L Disposable Bioreactor Run Using an NS0 Cell Line

We are delighted to announce today that WuXi Biologics division had completed a cell culture capacity expansion, including two 2000L disposable bioreactors that are ready for cGMP manufacturing. Previously WuXi had built a state-of-the-art...

WuXi Manufacturing Facility Passes FDA Inspection

WuXi is pleased to announce that STA, our small molecule API process R&D and manufacturing business unit, has completed a general GMP and Pre-Approval Inspection from the U.S. Food and Drug Administration with...

WuXi AppTec Receives CLIA Certification for its Genomics Clinical Laboratory

We are delighted to announce that WuXi's genomics clinical laboratory inShanghai has successfully passed the survey by theCenters for Medicare and Medicaid Services of theU.S. Department of Health and Human Services relating...

WuXi Employees Honored at ACS National Meeting

The global chemistry community met in Indiana this month for the 246th ACS National Meeting and Exposition. WuXi was at the event, and we had much to celebrate, with two of...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Artificial Intelligence Poised to Transform the Drug Industry from Laboratory to...

Artificial intelligence (AI) –  which learns from computer algorithms how to unravel complex genomic data, such as gene expression patterns of disease – is...